<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of ultrasound examination in obstetrics and gynecology</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of ultrasound examination in obstetrics and gynecology</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of ultrasound examination in obstetrics and gynecology</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas D Shipp, MD, RDMS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lynn L Simpson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Real-time sonographic imaging is the most common and most useful imaging technique employed in obstetrics and gynecology patients. However, it is a user-dependent imaging modality and multiple factors affect the images obtained, thereby directly affecting patient diagnosis and management. Operator experience and ability are probably the most important factors in making diagnoses that directly affect patient care. Other factors, such as the patient's body habitus, history of prior abdominal surgery, and, in obstetrics, fetal position, can all affect image quality and diagnostic performance.</p><p>Of note, over the past couple of decades, ultrasound equipment has progressively become smaller and is now available as laptop-sized and handheld systems [<a href="#rid1">1</a>]. These portable ultrasound systems can be used easily at the bedside (point-of-care ultrasound) and make ultrasound more available to users, especially in resource-limited settings, acutely ill patients, and emergencies [<a href="#rid2">2-4</a>]. </p><p>This topic will provide an overview of the use of ultrasound examination in obstetrics and gynecology. The use of ultrasound for specific applications is discussed in individual topics on the specific disorders. </p><p class="headingAnchor" id="H1797489913"><span class="h1">GYNECOLOGIC SONOGRAPHY</span></p><p class="headingAnchor" id="H2457131735"><span class="h2">Indications</span><span class="headingEndMark"> — </span>Gynecologic ultrasound examination has multiple uses, including, but not limited to, the conditions in the table  (<a class="graphic graphic_table graphicRef127761" href="/z/d/graphic/127761.html" rel="external">table 1</a>) [<a href="#rid5">5,6</a>]. Use of ultrasound for these indications is discussed in detail separately. (See independent topic reviews for each condition, where available.)</p><p class="headingAnchor" id="H2923814726"><span class="h2">Standard examination</span><span class="headingEndMark"> — </span>The components of a typical gynecologic sonographic examination include [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Uterine size, shape, and orientation – A general rule for uterine size is that in a woman of reproductive age, the uterus is 8 x 4 x 4 cm in the absence of fibroids or adenomyosis, and can be an additional 1 cm in each direction in multiparous women. The mean outer dimensions of the uterus among 263 premenopausal women (nulliparas, primiparas, multiparas) and menopausal women (less than or equal to five years of menopause and greater than five years of menopause) with no uterine or ovarian pathologic findings are shown in the table  (<a class="graphic graphic_table graphicRef76299" href="/z/d/graphic/76299.html" rel="external">table 2</a>). The average transverse width of uterine cavity (ie, inside dimension of the uterus) is 2.7 cm among nulliparas, 3.0 cm among primiparas, and 3.2 cm among multiparas [<a href="#rid8">8</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Appearance of the endometrium, myometrium, and cervix.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of the uterus and adnexa (ovaries, fallopian tubes) for masses, cysts, hydrosalpinges, fluid collections, and uterine/ovarian mobility.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation of the cul-de-sac for free fluid and masses.</p><p></p><p class="headingAnchor" id="H4157312154"><span class="h2">Utility of screening examinations</span><span class="headingEndMark"> — </span>In contrast to obstetric ultrasound, there is no role for routine ultrasound examination in asymptomatic nonpregnant women. The greatest area of interest in use of gynecologic ultrasound for screening is for ovarian cancer, with the goal of detecting malignancy at an early stage. However, in large randomized trials, annual transvaginal ultrasound did not result in a reduction of ovarian cancer mortality and had a high false-positive rate, which led to morbidity from surgery performed for benign lesions [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/7563.html" rel="external">"Screening for ovarian cancer", section on 'Transvaginal ultrasound (TVUS)'</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">OBSTETRIC SONOGRAPHY</span></p><p class="headingAnchor" id="H3011090429"><span class="h2">Timing and frequency</span><span class="headingEndMark"> — </span>The American College of Obstetricians and Gynecologists (ACOG) has recommended ultrasound examination for all pregnant patients [<a href="#rid10">10</a>]. The timing and frequency depend on the indication for the examination. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a single screening examination is performed, the optimal time is at 18 to 20 weeks of gestation. This represents a time when fetal development and current ultrasound technology allow for the optimal detection of fetal anomalies. Additional important information from this examination includes assessment of the placenta and umbilical cord (eg, location, placenta accreta spectrum), confirmation of singleton gestation or diagnosis of multiple gestation, assessment of cervical length (screening for short cervical length), and assessment of fetal growth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If two screening exams are performed, the first is typically done in the first trimester, either at 7 to 10 weeks for reliable assessment of pregnancy dating or, in settings of expertise, at 11 to 14 weeks for nuchal translucency examination, pregnancy dating, and an early fetal anatomic survey (which can detect at least 50 percent of major fetal abnormalities by 14 weeks). Increased nuchal translucency is a marker for some aneuploidies and genetic syndromes, congenital heart disease, and some noncardiac anomalies. In either time period, the first-trimester examination also assesses cardiac activity, number of fetuses, and, in multiple gestations, chorionicity and amnionicity. In some countries (not the United States), pulsed wave Doppler examination of the uterine arteries is performed at 11+0 to 14+0 weeks to assess uteroplacental impedance as part of an integrated early screening test for predicting preterm preeclampsia [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/z/d/html/435.html" rel="external">"Enlarged nuchal translucency and cystic hygroma"</a> and  <a class="medical medical_review" href="/z/d/html/6750.html" rel="external">"Early pregnancy prediction of preeclampsia"</a>.)</p><p></p><p class="bulletIndent1">The second screening examination is performed in the second trimester at 18 to 20 weeks for anatomic survey, growth, and pregnancy dating, as discussed above.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a third screening examination is performed in the third trimester, it is more pregnancy-specific with varied indications [<a href="#rid12">12</a>]. Major goals for all third-trimester scans are to assess fetal growth and amniotic fluid volume and screen for abnormalities that developed after or were not diagnosed on the 18 to 20 week examination. Common indications for third-trimester ultrasound screening examinations would include assessment of fetal growth in patients at risk for growth restriction or macrosomia, and assessment of the fetus for anomalies that are difficult to detect in the second trimester (for example heterozygous achondroplasia, where the femur length may not drop off the growth curve until the third trimester). </p><p></p><p class="bulletIndent1">Third-trimester scans are typically performed between 32 and 36 weeks. Patients at high risk for fetal growth restriction often have two third-trimester screening examinations, one at 32 weeks and the other at 36 weeks. (See  <a class="medical medical_review" href="/z/d/html/6752.html" rel="external">"Fetal growth restriction: Screening and diagnosis"</a>.)</p><p></p><p>In a retrospective cohort study of over 40,000 singleton pregnancies in a low-risk population that underwent standard sonography at 18 to 22 weeks of gestation with subsequent delivery of a live born infant, major anomalies were confirmed postnatally in 387 infants (1 percent) [<a href="#rid13">13</a>]. Among these infants, 281 were detected prenatally, of which 248 (64 percent) were detected at the initial fetal survey sonogram. Although one follow-up ultrasound improved the overall detection of anomalous fetuses from 64 to 71 percent, the yield was low in this low-risk population: 420 follow-up sonograms would need to be performed to detect an anomalous fetus not detected on the initial survey. In another large study, a previously undetected congenital malformation was incidentally detected in the third trimester in approximately 1 in 300 patients who were undergoing routine late pregnancy fetal growth assessment and had previous first- and second-trimester ultrasound screening [<a href="#rid14">14</a>]. The majority of these malformations involved the urinary tract, most commonly renal pelvic dilation, but also included neurologic abnormalities and skeletal dysplasia.</p><p>The natural history of some abnormalities limits the ability to dependably make a diagnosis at the 18 to 22 week fetal structural survey. Given the limited data, the current lack of clear practice recommendations, and the fact that some anomalies develop later in gestation and may not be identifiable at the first structural survey (eg, hypoplastic left heart syndrome, coarctation of the aorta [<a href="#rid15">15,16</a>]), follow-up structural surveys should be performed at the discretion of the obstetric provider and, if applicable, the consultant specialist. In the Paris Registry of Congenital Malformations, the anomalies most frequently missed prenatally but detected postnatally were genital anomalies; anomalies of the ear, neck or face; and limb anomalies [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H2766491653"><span class="h2">Indications</span><span class="headingEndMark"> — </span>The most common obstetric indications for ultrasound examination by trimester are listed in the table  (<a class="graphic graphic_table graphicRef58590" href="/z/d/graphic/58590.html" rel="external">table 3</a>) [<a href="#rid10">10,18</a>]. Use of ultrasound for these indications is discussed in detail separately. (See independent topic reviews for each condition, where available.)</p><p>In high-risk settings, a more detailed fetal examination may be indicated. Indications for a more detailed anatomic examination include but are not limited to [<a href="#rid19">19,20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fetus at increased risk for a genetic or congenital anomaly, based on past or present obstetric or family history of a genetic or congenital anomaly, maternal medical disorder (eg, diabetes, obesity), maternal teratogen exposure, conception by in vitro fertilization, increased nuchal translucency, multiple gestation, or abnormal antenatal blood screening</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Known or suspected fetal anomaly or known growth disorder (ie, early-onset growth restriction) in the current pregnancy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other conditions affecting the fetus, such as congenital infections, maternal opioid use disorder, alloimmunization, oligohydramnios or polyhydramnios</p><p></p><p class="headingAnchor" id="H752250213"><span class="h3">Nonmedical use</span><span class="headingEndMark"> — </span>Because of safety and other issues, there is consensus among national/international medical societies and regulatory bodies that prenatal ultrasonography should not be performed for nonmedical reasons, such as solely for parents to have a keepsake picture/video of the fetus, to learn the sex of the fetus without a medical indication, or for commercial demonstration purposes such as trade shows [<a href="#rid10">10,21,22</a>]. Likewise, Doppler ultrasound stethoscopes are available by prescription and should not be provided to parents to listen to the fetal heartbeat at home without a medical indication and guidelines for use [<a href="#rid21">21</a>]. (See <a class="local">'Safety'</a> below.)</p><p>ACOG has also added that nonmedical ultrasonography may falsely reassure women. Abnormalities may not be detected in these settings. Furthermore, these nonmedical providers are not prepared to discuss and provide follow-up of worrisome findings [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H1132363833"><span class="h2">Utility of routine examination</span><span class="headingEndMark"> — </span>Many meta-analyses of randomized trials have evaluated the utility of routine prenatal ultrasound examination. The included trials were generally of low or moderate quality. In particular, the late pregnancy trials used diverse definitions of screen positive, were designed in the absence of high-quality data on diagnostic effectiveness, did not couple screening to an effective intervention, and were underpowered for some outcomes (eg, perinatal mortality) [<a href="#rid23">23</a>]. With these limitations, the following findings have been reported:</p><p class="bulletIndent1"><span class="glyph">●</span>Compared with selective use, routine first-trimester ultrasound examination did not result in clear reductions of induction of labor for postterm pregnancy (RR 0.83, 95% CI 0.50-1.37) or perinatal loss (defined as miscarriage, termination of pregnancy, intrauterine death after trial entry, or death of a liveborn infant up to 28 days of age or before hospital discharge: RR 0.97, 95% CI 0.55-1.73), but appeared to reduce short-term maternal anxiety about the pregnancy (RR 0.80, 95% CI 0.65-0.99) [<a href="#rid24">24</a>]. However, the overall quality of data was not high given that the trials in the analysis were mostly from relatively early in the development of the technology, many control participants also had scans, and the trials were underpowered to show an effect on other important maternal or fetal outcomes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Compared with selective use, routine second-trimester ultrasound examination reduced the chances of induction of labor for postterm pregnancy (1.4 versus 2.8 percent; RR 0.48, 95% CI 0.31-0.73) and not detecting a multiple gestation by 24 to 26 weeks (RR 0.05, 95% CI 0.02-0.16) [<a href="#rid24">24</a>]. It also increased the changes of detecting a fetal anomaly by 24 weeks (RR 3.45,95% CI 1.67-7.12). However, there was no clear reduction in perinatal loss (RR 0.98, 95% CI 0.81-1.20). The overall quality of data was not high given that the trials in the analysis were mostly from relatively early in the development of the technology, many control participants also had scans, and the trials were underpowered to show an effect on other important maternal or fetal outcomes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Compared with selective use, routine ultrasound examination in late pregnancy (after 24 weeks of gestation) did not significantly reduce perinatal mortality (RR 1.01, 95% CI 0.67-1.54), preterm delivery (RR 0.96, 95% CI 0.85-1.08), or induction of labor (RR 0.93, 95% CI 0.81-1.07) but was not clearly harmful as it did not increase cesarean delivery rates (RR 1.02, 95% CI 0.97-1.09) [<a href="#rid25">25</a>]. Potential psychological effects and other neonatal outcomes could not be assessed.</p><p></p><p class="bulletIndent1">Similarly, compared with serial fundal height measurements, routine ultrasound examination in the third trimester did not reduce perinatal death in low-risk pregnancies (0.4 versus 0.3 percent, RR 1.14, 95% CI 0.68-1.89) [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Compared with no Doppler ultrasound, routine Doppler ultrasound in unselected low-risk populations did not significantly reduce perinatal mortality (RR 0.80, 95% CI 0.35-1.83) or serious neonatal morbidity (RR 0.99, 95% CI 0.06-15.75) [<a href="#rid27">27</a>]. Routine use of Doppler of fetal vessels/umbilical artery may have improved rates of stillbirth (RR 0.34, 95% CI 0.12-0.95). By contrast, a reduction in perinatal death has been observed in high-risk populations (RR 0.71, 95% CI 0.52-0.98) [<a href="#rid28">28</a>].</p><p></p><p class="headingAnchor" id="H2009320279"><span class="h2">Scope</span></p><p class="headingAnchor" id="H16"><span class="h3">Standard examination</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>4.5 to 8 weeks</strong> – An obstetric ultrasound examination between 4.5 and 8 weeks shows the size, location, and number of gestational sacs; the yolk sac at approximately 5.5 weeks and the embryo at approximately 6 weeks; and cardiac activity thereafter. </p><p></p><p class="bulletIndent1">In many multiple gestations, chorionicity and amnionicity are easily determined with high confidence at seven to eight weeks of gestation. In monochorionic twins, however, the amnion at seven to eight weeks is closely adherent to the embryo and may be difficult to detect.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>9 to 11 weeks</strong> – As the early pregnancy transitions from the embryonic to the fetal stage of development, more anatomy is identifiable sonographically. Some findings, such as the physiologic herniation of bowel, are normal and resolve by the end of this period. Some abnormal findings, such as holoprosencephaly, are identifiable during this time.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>12 to 14 weeks</strong> – The specific components of late first- versus second- and third-trimester examinations are described in detail in the American Institute of Ultrasound in Medicine-American College of Radiology-American College of Obstetricians and Gynecologists-Society for Maternal-Fetal Medicine-Society of Radiologists in Ultrasound (AIUM-ACR-ACOG-SMFM-SRU) Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations and the AIUM Practice Parameter for the Performance of Detailed Diagnostic Obstetric Ultrasound Examinations Between 12 Weeks 0 Days and 13 Weeks 6 Days, which are beyond the scope of this topic [<a href="#rid18">18,29</a>]. The ISUOG also has practice guidelines for performance of the 11-to 14-week ultrasound examination [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1">The detailed examination can be performed in the late first trimester in women at increased risk for fetal or placental abnormalities potentially detectable at this time [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>&gt;14 weeks</strong> – Standard obstetric ultrasound examination in the second and third trimester generally provides the following information [<a href="#rid10">10,18,19,30-32</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal number (chorionicity and amnionicity if multiple gestation). (See  <a class="medical medical_review" href="/z/d/html/6821.html" rel="external">"Twin pregnancy: Overview", section on 'Assessment of chorionicity and amnionicity'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal biometry – Fetal biometry is used to estimate gestational age and fetal weight, as appropriate for the stage of pregnancy. (See  <a class="medical medical_review" href="/z/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal presentation/malpresentation. (See  <a class="medical medical_review" href="/z/d/html/6776.html" rel="external">"Overview of breech presentation", section on 'Imaging'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Documentation of fetal cardiac activity, which may include rate and rhythm. (See  <a class="medical medical_review" href="/z/d/html/6765.html" rel="external">"Fetal arrhythmias"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Placental appearance and location, including the site of cord insertion into the placenta. (See  <a class="medical medical_review" href="/z/d/html/6772.html" rel="external">"Placenta previa: Epidemiology, clinical features, diagnosis, morbidity and mortality"</a> and  <a class="medical medical_review" href="/z/d/html/6759.html" rel="external">"Placenta accreta spectrum: Clinical features, diagnosis, and potential consequences"</a> and  <a class="medical medical_review" href="/z/d/html/6807.html" rel="external">"Velamentous umbilical cord insertion and vasa previa"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment of amniotic fluid volume. (See  <a class="medical medical_review" href="/z/d/html/462.html" rel="external">"Assessment of amniotic fluid volume"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Survey of fetal anatomy (calvarium, lateral ventricles, choroid plexus, falx cerebri, upper lip, nuchal region, four-chamber cardiac view, three-vessel trachea view, stomach, kidneys, bladder, cord insertion site at abdomen, limbs, genitalia in multiple gestations [and when medically indicated]). (See individual topic reviews for each anatomical region)</p><p></p><p class="bulletIndent2">In a study of early sonographic diagnosis of fetal sex that included over 2100 nonanomalous fetuses, accurate sex determination was often possible beginning at about a BPD of 18 mm (11.7 weeks), but the authors believed that fetal sex assignment should not be undertaken below a BPD of 22 mm (12.8 weeks) in cases where fetal sexing affected pregnancy management [<a href="#rid33">33</a>].   </p><p></p><p class="bulletIndent2">In some cases, the genital appearance may be atypical. (See  <a class="medical medical_review" href="/z/d/html/5803.html" rel="external">"Evaluation of the infant with atypical genital appearance (difference of sex development)"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maternal anatomy (cervix, uterus, adnexa, cul-de-sac). ACOG recommends examining the uterus, cervix, and adnexa when technically feasible [<a href="#rid10">10</a>]. AIUM and ACR affirm this position and further state that "a transperineal or transvaginal scan may be considered when evaluation of the cervix is needed" [<a href="#rid34">34,35</a>]. (See  <a class="medical medical_review" href="/z/d/html/450.html" rel="external">"Short cervix before 24 weeks: Screening and management in singleton pregnancies"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal movement. Temporary absence or reduction of fetal movement during an examination is not necessarily worrisome as it can be due to a normal fetal sleep cycle. (See  <a class="medical medical_review" href="/z/d/html/444.html" rel="external">"Decreased fetal movement: Diagnosis, evaluation, and management", section on 'Normal fetal movement'</a> and  <a class="medical medical_review" href="/z/d/html/5392.html" rel="external">"Biophysical profile test for antepartum fetal assessment"</a>.)</p><p></p><p>In-depth discussions of sonographic examination of the placental abnormalities, amniotic fluid volume, fetal growth abnormalities, fetal markers of aneuploidy, specific fetal anomalies, and other fetal and placental disorders can be found separately in individual topic reviews on each subject.</p><p class="headingAnchor" id="H17"><span class="h3">Limited examination</span><span class="headingEndMark"> — </span>Limited ultrasound examinations can be performed to address specific focused questions when an immediate impact on management is anticipated and when time or other constraints make performance of a standard examination impractical or unnecessary [<a href="#rid30">30,36</a>]. Examples of appropriate use of limited studies include confirmation of the presence, size, location, and number of gestational sac(s); presence or absence of fetal cardiac activity; checking fetal presentation; measuring cervical length; and assessment of amniotic fluid volume in conjunction with nonstress testing or assessment of fetal well-being with a biophysical profile [<a href="#rid10">10,34,36</a>]. </p><p>Ideally, a limited examination is performed in patients who have been previously evaluated by a complete examination. In women who have not previously had a standard or detailed ultrasound examination, a standard or detailed ultrasound examination should be obtained when and where appropriate.</p><p class="headingAnchor" id="H640917890"><span class="h3">Second- or third-trimester detailed examination</span><span class="headingEndMark"> — </span>A detailed (or specialized or comprehensive) fetal structural survey should only be undertaken by those with the necessary training and skills required for these advanced examinations. Indications for a detailed fetal examination include, but are not limited to, a previous pregnancy affected by a fetal anatomic or chromosomal abnormality; suspected, including those at increased risk for, or known fetal anatomic or chromosomal abnormality in the current pregnancy; known fetal growth disorder; and current pregnancy complications possibly affecting the fetus (eg, congenital infection, abnormal amniotic fluid volume, alloimmunization, suspected placenta accreta spectrum) [<a href="#rid19">19,31</a>]. Fetal evaluation in these settings requires a more detailed examination of fetal and placental anatomy than a standard fetal survey and requires more advanced skills and knowledge. </p><p>In 2013, a task force composed of participants from several major national obstetric and radiologic organizations in the United States developed a consensus report with guidelines for performance of this examination [<a href="#rid19">19</a>]. The detailed examination includes all of the elements of the standard examination. In addition, there are specific elements beyond those in the standard examination that are individualized and determined by the indication for the examination, the ultrasound findings identified during the examination, and the specialized knowledge and training of the responsible physician [<a href="#rid31">31</a>]. These elements may include evaluation of:</p><p class="bulletIndent1"><span class="glyph">●</span>Skull and intracranial anatomy, including all ventricles, choroid plexus, parenchyma, cisterna magna, cerebellar vermis, and corpus callosum</p><p class="bulletIndent1"><span class="glyph">●</span>Neck, including nuchal thickness</p><p class="bulletIndent1"><span class="glyph">●</span>Inner and outer facial structures (eg, profile, palate, orbits, lens, nose/nasal bone, jaw)</p><p class="bulletIndent1"><span class="glyph">●</span>Ears</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular anatomy (detailed evaluation beyond four chambers, outflow tracts, and three vessel thoracic view)</p><p class="bulletIndent1"><span class="glyph">●</span>Thorax, including diaphragm and lung masses/cysts, ribs</p><p class="bulletIndent1"><span class="glyph">●</span>Small and large bowel</p><p class="bulletIndent1"><span class="glyph">●</span>Adrenal glands</p><p class="bulletIndent1"><span class="glyph">●</span>Gallbladder, liver</p><p class="bulletIndent1"><span class="glyph">●</span>Spleen</p><p class="bulletIndent1"><span class="glyph">●</span>Kidneys and renal arteries</p><p class="bulletIndent1"><span class="glyph">●</span>Spine</p><p class="bulletIndent1"><span class="glyph">●</span>Limbs, including hands, feet, digits (number and position), humerus, femur, ulna, radius, tibia, fibula</p><p class="bulletIndent1"><span class="glyph">●</span>Genitalia</p><p class="bulletIndent1"><span class="glyph">●</span>Umbilical cord (structure)</p><p class="bulletIndent1"><span class="glyph">●</span>Placenta (lobes, masses, abnormal adherence)</p><p class="bulletIndent1"><span class="glyph">●</span>Neoplasms</p><p class="bulletIndent1"><span class="glyph">●</span>Expanded biometry</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal anatomy</p><p></p><p class="headingAnchor" id="H1945575922"><span class="h2">Safety</span><span class="headingEndMark"> — </span>No significant adverse effects have been identified in children exposed to obstetric ultrasound examination in utero and followed for several years after birth. (See <a class="local">'Evidence of effects in humans'</a> below.)</p><p class="headingAnchor" id="H2900079887"><span class="h3">Theoretical concerns about thermal effects, cavitation, and vibration</span><span class="headingEndMark"> — </span>The primary concerns of the use of ultrasound technology are with respect to thermal effects of the insonated tissue and cavitation of tissue due to the production of gas-filled bubbles [<a href="#rid37">37-39</a>]. The mechanical index (MI) is an estimate of the compressive and decompressive mechanical effects of ultrasound pulses (which can potentially result in cavitation), and the thermal index (TI) is an estimate of the degree of temperature elevation.</p><p>The temperature increase with diagnostic ultrasound is less than 1°C at typical acoustic output levels as long as the TI is maintained below 1.0. This level of increase is not felt to be clinically significant. Similarly, diagnostic ultrasound used for medical imaging does not appear to cause cavitation at usual obstetric acoustic output levels as long as the MI is kept below 1.0 [<a href="#rid39">39,40</a>].</p><p>The ultrasound wave affects the tissue through which it travels by mechanical vibration and heating of this tissue. Mechanical vibration can result in cavitation or the formation of gas bubbles. This is an effect that typically occurs at the interface of tissues and gas. Because there is no gas within the gestational sac, and specifically in the fetal lung or bowel, this is thought not to be a significant factor in obstetric sonography at the currently used levels of diagnostic sonography. Nevertheless, keeping MI &lt;1.0 is good practice.</p><p>Thermal effects have the greatest potential for adversely affecting the fetus. Routine B-mode, as is used for typical two-dimensional (2D) imaging, does not increase the temperature above the 1.0 to 1.5°C range that is thought to be safe for fetuses, especially those early embryos at the time of embryogenesis. Spectral Doppler ultrasound and, to a lesser extent, color Doppler ultrasound, however, use higher energy and focus the acoustic energy that is created on a much smaller volume of tissue than typical 2D imaging does and can result in changes in tissue temperature, especially at bone-tissue interfaces. For this reason, Doppler ultrasound should be used with great care, especially early in pregnancy, in spite of the lack of significant calcification of bone at this time [<a href="#rid37">37,41</a>].</p><p>The intensities used in transvaginal examinations are generally lower than those in transabdominal examinations. However, thermal risk can only be assessed by determining the TI in each case.</p><p class="headingAnchor" id="H2558889515"><span class="h3">Evidence of effects in humans</span><span class="headingEndMark"> — </span>In 2009, the World Health Organization (WHO) systematically reviewed 61 publications reporting data on the safety of B-mode or Doppler ultrasound in human pregnancy [<a href="#rid42">42</a>]. These data showed that ultrasonography during pregnancy was <strong>not</strong> associated with adverse maternal/fetal/neonatal outcome, impaired physical or neurologic development, increased risk of childhood malignancy, impaired cognitive ability, or mental disease. There was an unexplained weak association between ultrasound and non-righthandedness in boys. The weak association with non-righthandedness has also been reported in a meta-analysis of follow-up data of 8865 children ages 8 to 14 years from three randomized trials on routine ultrasonography at 15 to 20 weeks of gestation [<a href="#rid43">43</a>].</p><p>There were limitations to the WHO data, which prevent a firm conclusion about safety [<a href="#rid44">44</a>]. For example, the studies were observational and assessing bioeffects was not the primary objective, the intensity of ultrasound exposure was not usually measured, ultrasound technology changed over the period these studies were performed, and subtle and longer-term changes could have been missed. Nevertheless, the data are reassuring. In 2022, the AIUM noted that some older studies reported that fetal exposure to diagnostic ultrasound appeared to be associated with an increased risk of low birth weight, delayed speech, dyslexia, and non-right-handedness, but also noted that more recent studies have not demonstrated such effects despite higher maximum recommended levels of acoustic output for ultrasound machines used for fetal/obstetric applications [<a href="#rid45">45</a>]. As of this writing, there are no known deleterious effects of ultrasound when operating the machine using standard guidelines. Nevertheless, the overarching goal in pregnancy should be strict adherence to the ALARA (As Low As Reasonably Achievable) Principle using ultrasound with the lowest acoustic output possible for the least amount of time possible to acquire diagnostic images.</p><p>Pregnancy-related risk factors for development of autism spectrum disorder in childhood is an active area of investigation. No studies have found an association between the timing or frequency of prenatal ultrasound exposure and risk of autism spectrum disorder [<a href="#rid46">46-48</a>]. </p><p class="headingAnchor" id="H104774165"><span class="h3">Performance guidelines to maximize safety</span></p><p class="bulletIndent1"><span class="glyph">●</span>The use of ultrasound should be reserved for clear medical indications. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>B-mode and M-mode imaging operate at acoustic outputs that do not produce harmful temperature rises; therefore, temperature increases are typically not a concern. Nevertheless, scans should be performed over the shortest period of time and with the lowest energy output possible to permit adequate diagnostic accuracy [<a href="#rid49">49,50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast to B-mode and M-mode, the use of spectral and color (including power) Doppler ultrasound diagnostic equipment has greater time-averaged intensities and, therefore, the potential to produce biologically significant temperature rises, particularly in the vicinity of bone, which has high acoustic absorption and the potential for heating adjacent tissues. It is particularly important that sonologists who perform ultrasound imaging of first-trimester pregnancy understand the TI and MI acoustic output indices involved [<a href="#rid51">51</a>]. The potential for heating is also high when intracranial Doppler studies of the middle cerebral artery are performed in the second and third trimesters in fetuses at risk for anemia. The sonologist may interrogate a single location for a prolonged period of time during these studies, and since the location is near a bone tissue interface, it is important to pay attention to dwell time and move the probe frequently. (See <a class="local">'Theoretical concerns about thermal effects, cavitation, and vibration'</a> above.)</p><p></p><p class="bulletIndent1">Acoustic output is under the control of the operator. Use the minimum output and duration of Doppler insonation consistent with obtaining the required diagnostic information on the fetus. Altering the focal depth or the size of a box of interest or a Doppler gate will change the TI and MI. In addition, the effects of elevated temperatures may be minimized by keeping the time during which the beam passes through any one area as short as possible.</p><p></p><p class="bulletIndent1">The International Society of Ultrasound in Obstetrics and Gynecology Clinical Standards Committee developed practice guidelines and consensus statements to provide health care practitioners with a consensus-based approach for diagnostic imaging [<a href="#rid52">52,53</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>First-trimester use of fetal Doppler is a particular concern because of potential effects on organogenesis. Spectral Doppler, color flow imaging, power imaging, and other Doppler ultrasound modalities should generally be avoided in the embryonic period (up to 10+6 weeks of gestation). If information from Doppler is needed this early in gestation for pregnancy management, the exposure time should be kept to a minimum. As of 11+0 weeks, organogenesis is complete and the fetal-placental circulation is established so Doppler ultrasound modalities may be used for screening for specific clinical indications, such as screening for trisomy and cardiac anomalies. <strong>The TI should be ≤1.0 and exposure time should be kept as short as possible, usually no longer than 5 to 10 minutes and not exceeding 60 minutes</strong>. The minimal power output and duration of Doppler insonation required to obtain diagnostic information from the fetus should be used.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Doppler interrogation of maternal uterine arteries may be performed at any point in the first trimester without fetal safety concerns as long as the embryo/fetus lies outside the Doppler ultrasound beam.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ultrasound should be used with caution in febrile mothers because of the increased risks of potentially harmful heating [<a href="#rid54">54,55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The use of contrast agents in obstetric patients should be avoided because of the risk of nonthermal cavitational effects and the lack of data demonstrating efficacy and safety. Ultrasound contrast should not be used in pregnancy even in the absence of the use of Doppler [<a href="#rid54">54,55</a>].</p><p></p><p class="headingAnchor" id="H3828454879"><span class="h1">BASICS OF CLINICAL USE</span></p><p class="headingAnchor" id="H1693252783"><span class="h2">Personnel</span><span class="headingEndMark"> — </span>Sonography is an operator-dependent technology: A high level of proficiency can only be achieved by supervised experience with a large variety of normal and abnormal examinations.</p><p>In the United States, ultrasound examinations in obstetrics and gynecology are typically performed by diagnostic medical sonographers. Almost all of these health professionals are credentialed by the American Registry for Diagnostic Medical Sonography (ARDMS) and receive the credentials "RDMS" upon completion of extensive education, training, and testing. Some sonographers are also credentialed by the American Registry of Radiologic Technologists.</p><p>The examinations are supervised and interpreted by a sonologist, who is a physician with training and experience in this area. It is up to the physician to provide a report based on the data provided by the sonographer and, if indicated, by personally scanning the patient to confirm or modify the differential diagnosis. In the United States, the American Institute of Ultrasound in Medicine and the American College of Radiology have formulated guidelines for training, credentialing, continuing education, and ultrasound laboratory accreditation (available on the internet at <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aium.org%2F&amp;token=%2BCjrhIBVW0jZK35njTvgccv7gc02uhlLrYj2QvcSQ2w%3D&amp;TOPIC_ID=5388" target="_blank">www.aium.org</a> and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acr.org%2F&amp;token=IQxLzDq4doJGUgaZgeIY02siJ5t%2BidCLGI9Mfmzwqbg%3D&amp;TOPIC_ID=5388" target="_blank">www.acr.org</a>).</p><p class="headingAnchor" id="H882915523"><span class="h2">Ultrasound modalities</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>B-mode and M-mode</strong> – B-mode imaging, or brightness mode, is the most common technique for imaging in obstetrics and gynecology. M-mode, or motion mode, is useful for evaluating the fetal heart (eg, rate and rhythm, valve motion). (See  <a class="medical medical_review" href="/z/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management"</a> and  <a class="medical medical_review" href="/z/d/html/6765.html" rel="external">"Fetal arrhythmias"</a>.)</p><p></p><p class="bulletIndent1">Almost all obstetric and gynecologic sonography is done in real time, freely moving the probe to view each structure from multiple orientations. It is primarily used to evaluate morphology and is especially useful for studying the anatomy of moving objects, such as the fetus, or for evaluation of the movement of structures, such as the ovaries and cul-de-sac, with suspected endometriosis. Biometric measurements are typically performed on the display monitor from a frozen image.</p><p></p><p class="bulletIndent1">Real-time evaluation of fetal movement, breathing, and tone form the basis of one of the two main tests of fetal well-being: the biophysical profile. (See  <a class="medical medical_review" href="/z/d/html/5392.html" rel="external">"Biophysical profile test for antepartum fetal assessment"</a>.)</p><p></p><p class="bulletIndent1">Real-time imaging is also used to guide invasive obstetric procedures, such as amniocentesis, chorionic villus sampling, and fetal blood sampling and/or transfusion. (See  <a class="medical medical_review" href="/z/d/html/5390.html" rel="external">"Diagnostic amniocentesis"</a> and  <a class="medical medical_review" href="/z/d/html/449.html" rel="external">"Chorionic villus sampling"</a> and  <a class="medical medical_review" href="/z/d/html/5389.html" rel="external">"Fetal blood sampling"</a> and  <a class="medical medical_review" href="/z/d/html/5385.html" rel="external">"Intrauterine fetal transfusion of red blood cells"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Doppler ultrasound</strong> – Doppler ultrasound is used for studying most of the major fetal circulatory systems and is particularly helpful in evaluating the functional state of the fetal cardiovascular system, fetoplacental and uteroplacental blood flow, and pelvic cysts and tumors. Several modalities are available (continuous wave, pulsed wave [spectral Doppler], color flow mapping, power). The choice depends on the information needed (eg, fetal heart rate versus velocity and direction of blood flow); more than one modality can be used.</p><p></p><p class="bulletIndent1">Specific clinical uses of Doppler ultrasound include, but are not limited to, the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment of fetal well-being in pregnancies complicated by fetal growth restriction. (See  <a class="medical medical_review" href="/z/d/html/139556.html" rel="external">"Fetal growth restriction: Pregnancy management and outcome", section on 'Fetal surveillance'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of fetal anemia by assessment of peak systolic flow in the middle cerebral artery. (See  <a class="medical medical_review" href="/z/d/html/6802.html" rel="external">"RhD alloimmunization in pregnancy: Management", section on 'Assess for severe anemia using MCA-PSV in fetuses at risk'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of the maternal-placental interface in the diagnostic evaluation of the placenta accreta spectrum. (See  <a class="medical medical_review" href="/z/d/html/6759.html" rel="external">"Placenta accreta spectrum: Clinical features, diagnosis, and potential consequences", section on 'Color Doppler'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation of suspected vasa previa. (See  <a class="medical medical_review" href="/z/d/html/6807.html" rel="external">"Velamentous umbilical cord insertion and vasa previa", section on 'Imaging'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assessment of blood flow to suspected ovarian and endometrial tumors. (See  <a class="medical medical_review" href="/z/d/html/3208.html" rel="external">"Adnexal mass: Ultrasound categorization"</a> and  <a class="medical medical_review" href="/z/d/html/3232.html" rel="external">"Overview of the evaluation of the endometrium for malignant or premalignant disease", section on 'Transvaginal ultrasound'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Advanced techniques</strong> – The following clinical techniques are used selectively to provide further evaluation of uncertain findings on real-time grey-scale two-dimensional (2D) sonography or allow a more expansive evaluation not available with standard grey-scale sonography [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Three-dimensional (3D) sonography</strong> – The use of this technique can reduce scanning time while maintaining adequate visualization of the fetus in obstetric ultrasound and the pelvis in gynecologic ultrasound [<a href="#rid57">57-59</a>]. Surface rendering of the fetus with 3D sonography can better demonstrate abnormalities previously detected with 2D sonography, especially facial, skeletal, and central nervous system abnormalities.</p><p></p><p class="bulletIndent2">In gynecology, the coronal plane of the uterus is easily obtained with 3D but not 2D sonography, thus enhancing visualization of the uterus, especially the uterine cavity. This has improved the ability of sonography to diagnose uterine anomalies [<a href="#rid60">60</a>] and identify malposition of intrauterine devices [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Four-dimensional (4D) sonography</strong> – Four-dimensional sonography (also called dynamic 3D sonography) refers to 3D images that can be viewed in real time. It has been used to study the fetal heart, fetal movement, and fetal behavioral states.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sonohysterography</strong> – <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">Saline</a> infusion sonohysterography refers to a procedure in which fluid is instilled into the uterine cavity transcervically to provide enhanced endometrial visualization during transvaginal ultrasound examination. Rarely, the examination is performed transabdominally, such as when the uterus is lifted out of the pelvis, usually by fibroids and less commonly by adhesions. (See  <a class="medical medical_review" href="/z/d/html/3252.html" rel="external">"Saline infusion sonohysterography"</a>.)</p><p></p><p class="bulletIndent2">As an extension of sonohysterography, hysterosalpingo contrast sonography (HyCoSy) is particularly useful for evaluation of tubal patency. Although contrast agents can be used, <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> with "microbubbles" (ie, saline agitated with air) can provide valuable information noninvasively [<a href="#rid62">62</a>]. (See  <a class="medical medical_review" href="/z/d/html/5445.html" rel="external">"Female infertility: Evaluation", section on 'Hysterosalpingo-contrast sonography'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Elastography </strong>– Elastography assesses the elastic properties of tissues and is an area of active research in obstetrics and gynecology. Although not currently standard of care, investigative work has included evaluation of the cervix for assessment of risk for preterm birth [<a href="#rid63">63</a>] among many other areas of obstetrics and gynecology.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Slow-flow microvascular Doppler ultrasound</strong> – Slow-flow microvascular Doppler ultrasound is a new technology that identifies slower flow in smaller vessels. It appears to be safe in obstetrics as safety indices are well within recommended values [<a href="#rid64">64</a>]. Given its recent availability, its use in obstetrics and gynecology requires further study.</p><p></p><p class="headingAnchor" id="H4288219112"><span class="h2">Patient preparation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reason for the examination</strong> – The sonographer should know the indication for the ultrasound examination and results of other evaluations related to the patient's problem. The last menstrual period (or estimated delivery date in obstetric examinations) should be documented. All of this information is critical for targeting specific structures, choosing whether to use a transvaginal and/or transabdominal technique, and deciding whether additional studies may be helpful (eg, <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> infusion sonohysterography, Doppler velocimetry).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient position</strong> – In obstetrics and gynecology, most examinations are performed with the woman in a semi-recumbent position. A padded table and pillows provide reasonable comfort. It is desirable to be able to elevate the head of the bed because many pregnant women are unable to lie flat, especially later in pregnancy. Others will require pillows under their knees or behind their back to achieve a comfortable position.</p><p></p><p class="bulletIndent1">Transvaginal ultrasound examinations are done with the woman in a lithotomy position. Alternatively, a cushion can be placed under the buttocks to raise the pelvis, while the lower extremities are separated and/or frog-legged (soles of feet together and knees apart).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Modifications for patients with obesity</strong> – Abdominal obesity limits the technical quality of the ultrasound examination. Imaging may be improved by having the patient lie on her side and placing the transducer at the side of the maternal abdomen rather than in the midline where the thickness of abdominal adipose tissue is often greater, and/or by use of transvaginal ultrasound.</p><p></p><p class="bulletIndent1">Although fetal anatomic surveys for malformations are typically performed transabdominally at 18 to 20 weeks, performing the examination later in gestation (20 to 22 weeks) in the obese gravida may improve visualization of anatomy [<a href="#rid65">65</a>]. Transvaginal ultrasound in the late first or early second trimester may also help with fetal evaluation in these patients [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bladder filling</strong> – In transabdominal obstetric examinations, there is little benefit to the patient having a full bladder, and it has drawbacks (eg, false diagnosis of placenta previa or falsely elongated cervix). Urine in the bladder is useful when the area of the lower uterine segment is of interest as it can provide a helpful window for the evaluation. In transabdominal gynecologic examinations, the bladder does not have to be full; however, if the uterus and ovaries cannot be seen well, it may be necessary to have the patient fill her bladder to a comfortable capacity.</p><p></p><p class="bulletIndent1">Transvaginal sonography is usually performed with an empty bladder.</p><p></p><p class="headingAnchor" id="H3403539242"><span class="h1">REMOTE INTERPRETATION OF IMAGES</span><span class="headingEndMark"> — </span>Both two-dimensional ultrasound images and three-dimensional datasets can be sent electronically for evaluation by experts [<a href="#rid57">57-59</a>] or to facilitate consultation between a patient or referring physician and a specialist [<a href="#rid67">67</a>]. The transfer of ultrasound images can be easily accomplished using the Digital Imaging and Communications in Medicine (DICOM) protocol, which is an international standard for exchange, storage and communication of digital medical images and other related digital data [<a href="#rid67">67</a>]. Provision of such consultative services to resource-limited or remote areas allows access to clinical expertise and potential improvements in diagnosis and management that may not have otherwise happened.</p><p class="headingAnchor" id="H971333348"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/123103.html" rel="external">"Society guideline links: Ultrasound imaging in pregnancy"</a>.)</p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for obstetric and gynecologic ultrasound examination</strong> – The indications for obstetric ultrasound examination vary by trimester and are listed in the table  (<a class="graphic graphic_table graphicRef58590" href="/z/d/graphic/58590.html" rel="external">table 3</a>) (see <a class="local">'Indications'</a> above). Gynecologic ultrasound examination has multiple uses for diagnosis of pelvic disorders and abnormalities  (<a class="graphic graphic_table graphicRef127761" href="/z/d/graphic/127761.html" rel="external">table 1</a>). (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The American College of Obstetricians and Gynecologists and others have recommended ultrasound examination for all pregnant patients. The timing and frequency depend on the indication for the examination. If only a single screening examination is performed, the optimal time is at 18 to 20 weeks of gestation. (See <a class="local">'Obstetric sonography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Standard components</strong> – Suggested components of a standard obstetric and gynecologic evaluation have been outlined by various groups. (See <a class="local">'Scope'</a> above and <a class="local">'Standard examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Safety considerations</strong> – Diagnostic ultrasound examination used appropriately has no harmful effects (including fetal effects). Nevertheless, examinations should be performed only for valid medical reasons, for the shortest amount of time, and with the lowest level of acoustic energy that allows diagnostic evaluation. (See <a class="local">'Safety'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical use</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sonography is an operator-dependent technology: A high level of proficiency can only be achieved by supervised experience with a large variety of normal and abnormal examinations. (See <a class="local">'Personnel'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Several ultrasound modalities are available; the choice depends on the information needed. (See <a class="local">'Ultrasound modalities'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Baran JM, Webster JG. Design of low-cost portable ultrasound systems: review. Conf Proc IEEE Eng Med Biol Soc 2009; 2009:792.</a></li><li><a class="nounderline abstract_t">Harris RD, Marks WM. Compact ultrasound for improving maternal and perinatal care in low-resource settings: review of the potential benefits, implementation challenges, and public health issues. J Ultrasound Med 2009; 28:1067.</a></li><li><a class="nounderline abstract_t">Spencer JK, Adler RS. Utility of portable ultrasound in a community in Ghana. J Ultrasound Med 2008; 27:1735.</a></li><li><a class="nounderline abstract_t">Easter SR, Hameed AB, Shamshirsaz A, et al. Point of care maternal ultrasound in obstetrics. Am J Obstet Gynecol 2023; 228:509.e1.</a></li><li><a class="nounderline abstract_t">AIUM Practice Parameter for the Performance of an Ultrasound Examination of the Female Pelvis. J Ultrasound Med 2020; 39:E17.</a></li><li class="breakAll">AIUM Practice Parameter for Ultrasound Examinations in Reproductive Medicine and Infertility https://www.aium.org/resources/guidelines/reproductiveMed.pdf.</li><li><a class="nounderline abstract_t">American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of pelvic ultrasound examinations. J Ultrasound Med 2010; 29:166.</a></li><li><a class="nounderline abstract_t">Benacerraf BR, Shipp TD, Lyons JG, Bromley B. Width of the normal uterine cavity in premenopausal women and effect of parity. Obstet Gynecol 2010; 116:305.</a></li><li><a class="nounderline abstract_t">Henderson JT, Webber EM, Sawaya GF. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2018; 319:595.</a></li><li><a class="nounderline abstract_t">Committee on Practice Bulletins—Obstetrics and the American Institute of Ultrasound in Medicine. Practice Bulletin No. 175: Ultrasound in Pregnancy. Obstet Gynecol 2016; 128:e241. Reaffirmed 2022.</a></li><li><a class="nounderline abstract_t">International Society of Ultrasound in Obstetrics and Gynecology, Bilardo CM, Chaoui R, et al. ISUOG Practice Guidelines (updated): performance of 11-14-week ultrasound scan. Ultrasound Obstet Gynecol 2023; 61:127.</a></li><li><a class="nounderline abstract_t">Khalil A, Sotiriadis A, D'Antonio F, et al. ISUOG Practice Guidelines: performance of third-trimester obstetric ultrasound scan. Ultrasound Obstet Gynecol 2024; 63:131.</a></li><li><a class="nounderline abstract_t">Byrne JJ, Morgan JL, Twickler DM, et al. Utility of follow-up standard sonography for fetal anomaly detection. Am J Obstet Gynecol 2020; 222:615.e1.</a></li><li><a class="nounderline abstract_t">Drukker L, Cavallaro A, Salim I, et al. How often do we incidentally find a fetal abnormality at the routine third-trimester growth scan? A population-based study. Am J Obstet Gynecol 2020; 223:919.e1.</a></li><li><a class="nounderline abstract_t">Morgan CT, Mueller B, Thakur V, et al. Improving Prenatal Diagnosis of Coarctation of the Aorta. Can J Cardiol 2019; 35:453.</a></li><li><a class="nounderline abstract_t">Freud LR, Moon-Grady A, Escobar-Diaz MC, et al. Low rate of prenatal diagnosis among neonates with critical aortic stenosis: insight into the natural history in utero. Ultrasound Obstet Gynecol 2015; 45:326.</a></li><li><a class="nounderline abstract_t">Monier I, Lelong N, Benachi A, et al. Postnatal diagnosis of congenital anomalies despite active systematic prenatal screening policies: a population-based registry study. Am J Obstet Gynecol MFM 2023; 5:101170.</a></li><li><a class="nounderline abstract_t">AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations. J Ultrasound Med 2018; 37:E13. (available online at https://onlinelibrary.wiley.com/doi/10.1002/jum.14831)</a></li><li><a class="nounderline abstract_t">Wax J, Minkoff H, Johnson A, et al. Consensus report on the detailed fetal anatomic ultrasound examination: indications, components, and qualifications. J Ultrasound Med 2014; 33:189.</a></li><li><a class="nounderline abstract_t">De Robertis V, Calì G, Corbella P, et al. Referral scan for congenital anomalies: time to agree on indications. Ultrasound Obstet Gynecol 2022; 60:597.</a></li><li><a class="nounderline abstract_t">Phillips RA, Stratmeyer ME, Harris GR. Safety and U.S. Regulatory considerations in the nonclinical use of medical ultrasound devices. Ultrasound Med Biol 2010; 36:1224.</a></li><li><a class="nounderline abstract_t">Salvesen K, Abramowicz J, Ter Haar G, et al. ISUOG statement on the non-diagnostic use of ultrasound in pregnancy. Ultrasound Obstet Gynecol 2021; 58:147.</a></li><li><a class="nounderline abstract_t">Smith G. A critical review of the Cochrane meta-analysis of routine late-pregnancy ultrasound. BJOG 2021; 128:207.</a></li><li><a class="nounderline abstract_t">Kaelin Agten A, Xia J, Servante JA, et al. Routine ultrasound for fetal assessment before 24 weeks' gestation. Cochrane Database Syst Rev 2021; 8:CD014698.</a></li><li><a class="nounderline abstract_t">Bricker L, Medley N, Pratt JJ. Routine ultrasound in late pregnancy (after 24 weeks' gestation). Cochrane Database Syst Rev 2015; :CD001451.</a></li><li><a class="nounderline abstract_t">Al-Hafez L, Chauhan SP, Riegel M, et al. Routine third-trimester ultrasound in low-risk pregnancies and perinatal death: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020; 2:100242.</a></li><li><a class="nounderline abstract_t">Alfirevic Z, Stampalija T, Medley N. Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database Syst Rev 2015; :CD001450.</a></li><li><a class="nounderline abstract_t">Alfirevic Z, Stampalija T, Dowswell T. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2017; 6:CD007529.</a></li><li><a class="nounderline abstract_t">AIUM Practice Parameter for the Performance of Detailed Diagnostic Obstetric Ultrasound Examinations Between 12 Weeks 0 Days and 13 Weeks 6 Days. J Ultrasound Med 2021; 40:E1.</a></li><li class="breakAll">AIUM–ACR–ACOG–SMFM–SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations https://onlinelibrary.wiley.com/doi/10.1002/jum.14831 (Accessed on October 23, 2018).</li><li><a class="nounderline abstract_t">AIUM Practice Parameter for the Performance of Detailed Second- and Third-Trimester Diagnostic Obstetric Ultrasound Examinations. J Ultrasound Med 2019; 38:3093.</a></li><li><a class="nounderline abstract_t">Salomon LJ, Alfirevic Z, Berghella V, et al. ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2022; 59:840.</a></li><li><a class="nounderline abstract_t">Mazza V, Di Monte I, Pati M, et al. Sonographic biometrical range of external genitalia differentiation in the first trimester of pregnancy: analysis of 2593 cases. Prenat Diagn 2004; 24:677.</a></li><li class="breakAll">American Institute of Ultrasound in Medicine, Standards AIUM Practice Guideline for the performance of the antepartum obstetrical ultrasound examinations. American Institute of Ultrasound in Medicine, Laurel, MD 2007.</li><li class="breakAll">Glanc P, Bhosale PR, Harris RD, et al. Expert Panel on Women's Imaging. ACR appropriateness criteria assessment of gravid cervix [online publication]. Reston (VA): American College of Radiology (ACR); 2014.</li><li><a class="nounderline abstract_t">AIUM Practice Parameter for the Performance of Limited Obstetric Ultrasound Examinations by Advanced Clinical Providers. J Ultrasound Med 2018; 37:1587.</a></li><li class="breakAll">Callen PW. The obstetric ultrasound examination. In: Ultrasonography in Obstetrics and Gynecology, 4th ed, Callen PW (Ed), WB Saunders Company, New York 2000.</li><li><a class="nounderline abstract_t">Reece EA, Assimakopoulos E, Zheng XZ, et al. The safety of obstetric ultrasonography: concern for the fetus. Obstet Gynecol 1990; 76:139.</a></li><li><a class="nounderline abstract_t">Miller MW, Brayman AA, Abramowicz JS. Obstetric ultrasonography: a biophysical consideration of patient safety--the "rules" have changed. Am J Obstet Gynecol 1998; 179:241.</a></li><li><a class="nounderline abstract_t">ACOG committee opinion. New ultrasound output display standard. Number 180, November 1996. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1997; 57:227.</a></li><li><a class="nounderline abstract_t">Abramowicz JS, Kossoff G, Marsal K, et al. Safety Statement, 2000 (reconfirmed 2003). International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Ultrasound Obstet Gynecol 2003; 21:100.</a></li><li><a class="nounderline abstract_t">Torloni MR, Vedmedovska N, Merialdi M, et al. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol 2009; 33:599.</a></li><li><a class="nounderline abstract_t">Salvesen KÅ. Ultrasound in pregnancy and non-right handedness: meta-analysis of randomized trials. Ultrasound Obstet Gynecol 2011; 38:267.</a></li><li><a class="nounderline abstract_t">Salvesen KA, Lees C. Ultrasound is not unsound, but safety is an issue. Ultrasound Obstet Gynecol 2009; 33:502.</a></li><li><a class="nounderline abstract_t">AIUM Official Statement: Conclusions Regarding Epidemiology for Obstetric Ultrasound. J Ultrasound Med 2023; 42:E11.</a></li><li><a class="nounderline abstract_t">Höglund Carlsson L, Saltvedt S, Anderlid BM, et al. Prenatal ultrasound and childhood autism: long-term follow-up after a randomized controlled trial of first- vs second-trimester ultrasound. Ultrasound Obstet Gynecol 2016; 48:285.</a></li><li><a class="nounderline abstract_t">Rosman NP, Vassar R, Doros G, et al. Association of Prenatal Ultrasonography and Autism Spectrum Disorder. JAMA Pediatr 2018; 172:336.</a></li><li><a class="nounderline abstract_t">Stoch YK, Williams CJ, Granich J, et al. Are prenatal ultrasound scans associated with the autism phenotype? Follow-up of a randomised controlled trial. J Autism Dev Disord 2012; 42:2693.</a></li><li><a class="nounderline abstract_t">AIUM Official Statement for Recommended Maximum Scanning Times for Displayed Thermal Index Values. J Ultrasound Med 2023; 42:E74.</a></li><li class="breakAll">AIUM guidelines for obstetric ultrasound https://www.aium.org/accreditation/obstetric (Accessed on November 27, 2023).</li><li><a class="nounderline abstract_t">Sheiner E, Shoham-Vardi I, Abramowicz JS. What do clinical users know regarding safety of ultrasound during pregnancy? J Ultrasound Med 2007; 26:319.</a></li><li><a class="nounderline abstract_t">Salvesen K, Abramowicz J, Ter Haar G, et al. ISUOG statement on the safe use of Doppler for fetal ultrasound examination in the first 13 + 6 weeks of pregnancy (updated). Ultrasound Obstet Gynecol 2021; 57:1020.</a></li><li><a class="nounderline abstract_t">Bhide A, Acharya G, Baschat A, et al. ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics. Ultrasound Obstet Gynecol 2021; 58:331.</a></li><li><a class="nounderline abstract_t">Bly S, Van den Hof MC, Diagnostic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada. Obstetric ultrasound biological effects and safety. J Obstet Gynaecol Can 2005; 27:572.</a></li><li><a class="nounderline abstract_t">Abramowicz JS. Fetal Doppler: how to keep it safe? Clin Obstet Gynecol 2010; 53:842.</a></li><li><a class="nounderline abstract_t">Whittingham TA. New and future developments in ultrasonic imaging. Br J Radiol 1997; 70 Spec No:S119.</a></li><li><a class="nounderline abstract_t">Benacerraf BR, Shipp TD, Bromley B. How sonographic tomography will change the face of obstetric sonography: a pilot study. J Ultrasound Med 2005; 24:371.</a></li><li><a class="nounderline abstract_t">Benacerraf BR, Shipp TD, Bromley B. Improving the efficiency of gynecologic sonography with 3-dimensional volumes: a pilot study. J Ultrasound Med 2006; 25:165.</a></li><li><a class="nounderline abstract_t">Benacerraf BR, Shipp TD, Bromley B. Three-dimensional US of the fetus: volume imaging. Radiology 2006; 238:988.</a></li><li><a class="nounderline abstract_t">Bermejo C, Martínez Ten P, Cantarero R, et al. Three-dimensional ultrasound in the diagnosis of Müllerian duct anomalies and concordance with magnetic resonance imaging. Ultrasound Obstet Gynecol 2010; 35:593.</a></li><li><a class="nounderline abstract_t">Benacerraf BR, Shipp TD, Bromley B. Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding. Ultrasound Obstet Gynecol 2009; 34:110.</a></li><li><a class="nounderline abstract_t">Wang Y, Qian L. Three- or four-dimensional hysterosalpingo contrast sonography for diagnosing tubal patency in infertile females: a systematic review with meta-analysis. Br J Radiol 2016; 89:20151013.</a></li><li><a class="nounderline abstract_t">Patberg ET, Wells M, Vahanian SA, et al. Use of cervical elastography at 18 to 22 weeks' gestation in the prediction of spontaneous preterm birth. Am J Obstet Gynecol 2021; 225:525.e1.</a></li><li><a class="nounderline abstract_t">Drukker L, Droste R, Ioannou C, et al. Function and Safety of SlowflowHD Ultrasound Doppler in Obstetrics. Ultrasound Med Biol 2022; 48:1157.</a></li><li><a class="nounderline abstract_t">Reddy UM, Abuhamad AZ, Levine D, et al. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging workshop. Obstet Gynecol 2014; 123:1070.</a></li><li><a class="nounderline abstract_t">Romary L, Sinkovskaya E, Ali S, et al. The Role of Early Gestation Ultrasound in the Assessment of Fetal Anatomy in Maternal Obesity. J Ultrasound Med 2017; 36:1161.</a></li><li class="breakAll">Williams EA, Iriye BK, O'Keefe D. White Paper - Telemedicine in the MFM setting. Association for Maternal Fetal Medicine Management 2014. http://new.amfmm.com/Portals/0/Documents/Telemedicine-In-The-MFM-Setting.pdf (Accessed on October 01, 2014).</li></ol></div><div id="topicVersionRevision">Topic 5388 Version 61.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19963733" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Design of low-cost portable ultrasound systems: review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19643790" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Compact ultrasound for improving maternal and perinatal care in low-resource settings: review of the potential benefits, implementation challenges, and public health issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19022999" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Utility of portable ultrasound in a community in Ghana.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36183775" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Point of care maternal ultrasound in obstetrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32150295" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : AIUM Practice Parameter for the Performance of an Ultrasound Examination of the Female Pelvis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32150295" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : AIUM Practice Parameter for the Performance of an Ultrasound Examination of the Female Pelvis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20040793" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : AIUM practice guideline for the performance of pelvic ultrasound examinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664389" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Width of the normal uterine cavity in premenopausal women and effect of parity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29450530" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27875472" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Practice Bulletin No. 175: Ultrasound in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36594739" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : ISUOG Practice Guidelines (updated): performance of 11-14-week ultrasound scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38166001" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : ISUOG Practice Guidelines: performance of third-trimester obstetric ultrasound scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31930994" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Utility of follow-up standard sonography for fetal anomaly detection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32504567" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : How often do we incidentally find a fetal abnormality at the routine third-trimester growth scan? A population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30935636" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Improving Prenatal Diagnosis of Coarctation of the Aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25251721" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Low rate of prenatal diagnosis among neonates with critical aortic stenosis: insight into the natural history in utero.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37783275" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Postnatal diagnosis of congenital anomalies despite active systematic prenatal screening policies: a population-based registry study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30308091" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24449720" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Consensus report on the detailed fetal anatomic ultrasound examination: indications, components, and qualifications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35633512" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Referral scan for congenital anomalies: time to agree on indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20447750" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Safety and U.S. Regulatory considerations in the nonclinical use of medical ultrasound devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34198364" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : ISUOG statement on the non-diagnostic use of ultrasound in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32598533" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A critical review of the Cochrane meta-analysis of routine late-pregnancy ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34438475" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Routine ultrasound for fetal assessment before 24 weeks' gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26121659" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Routine ultrasound in late pregnancy (after 24 weeks' gestation).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33345941" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Routine third-trimester ultrasound in low-risk pregnancies and perinatal death: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25874722" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Fetal and umbilical Doppler ultrasound in normal pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28613398" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Fetal and umbilical Doppler ultrasound in high-risk pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32852128" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : AIUM Practice Parameter for the Performance of Detailed Diagnostic Obstetric Ultrasound Examinations Between 12 Weeks 0 Days and 13 Weeks 6 Days.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32852128" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : AIUM Practice Parameter for the Performance of Detailed Diagnostic Obstetric Ultrasound Examinations Between 12 Weeks 0 Days and 13 Weeks 6 Days.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31736130" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : AIUM Practice Parameter for the Performance of Detailed Second- and Third-Trimester Diagnostic Obstetric Ultrasound Examinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35592929" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15386456" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sonographic biometrical range of external genitalia differentiation in the first trimester of pregnancy: analysis of 2593 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15386456" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Sonographic biometrical range of external genitalia differentiation in the first trimester of pregnancy: analysis of 2593 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15386456" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Sonographic biometrical range of external genitalia differentiation in the first trimester of pregnancy: analysis of 2593 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30133848" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : AIUM Practice Parameter for the Performance of Limited Obstetric Ultrasound Examinations by Advanced Clinical Providers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30133848" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : AIUM Practice Parameter for the Performance of Limited Obstetric Ultrasound Examinations by Advanced Clinical Providers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2193264" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The safety of obstetric ultrasonography: concern for the fetus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9704794" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Obstetric ultrasonography: a biophysical consideration of patient safety--the "rules" have changed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9184970" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : ACOG committee opinion. New ultrasound output display standard. Number 180, November 1996. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12528176" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Safety Statement, 2000 (reconfirmed 2003). International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19291813" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21584892" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Ultrasound in pregnancy and non-right handedness: meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19402099" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Ultrasound is not unsound, but safety is an issue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36573616" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : AIUM Official Statement: Conclusions Regarding Epidemiology for Obstetric Ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27184020" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prenatal ultrasound and childhood autism: long-term follow-up after a randomized controlled trial of first- vs second-trimester ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29435580" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Association of Prenatal Ultrasonography and Autism Spectrum Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22456820" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Are prenatal ultrasound scans associated with the autism phenotype? Follow-up of a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37638782" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : AIUM Official Statement for Recommended Maximum Scanning Times for Displayed Thermal Index Values.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37638782" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : AIUM Official Statement for Recommended Maximum Scanning Times for Displayed Thermal Index Values.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17324981" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : What do clinical users know regarding safety of ultrasound during pregnancy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34077607" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : ISUOG statement on the safe use of Doppler for fetal ultrasound examination in the first 13 + 6 weeks of pregnancy (updated).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34278615" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16100635" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Obstetric ultrasound biological effects and safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21048451" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Fetal Doppler: how to keep it safe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9534725" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : New and future developments in ultrasonic imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15723850" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : How sonographic tomography will change the face of obstetric sonography: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16439779" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Improving the efficiency of gynecologic sonography with 3-dimensional volumes: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16424249" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Three-dimensional US of the fetus: volume imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20052665" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Three-dimensional ultrasound in the diagnosis of Müllerian duct anomalies and concordance with magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19565532" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27109737" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Three- or four-dimensional hysterosalpingo contrast sonography for diagnosing tubal patency in infertile females: a systematic review with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34051170" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Use of cervical elastography at 18 to 22 weeks' gestation in the prediction of spontaneous preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35300877" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Function and Safety of SlowflowHD Ultrasound Doppler in Obstetrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24785860" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging workshop.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28417475" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The Role of Early Gestation Ultrasound in the Assessment of Fetal Anatomy in Maternal Obesity.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
